Antihypertensive efficacy of angiotensin converting enzyme inhibition and aspirin counteraction (Q74182594)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9465844%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Antihypertensive efficacy of angiotensin converting enzyme inhibition and aspirin counteraction (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9465844%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9465844%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Daniela Trabattoni

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9465844%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

Guazzi MD

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9465844%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Campodonico J

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9465844%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Celeste F

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9465844%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Guazzi M

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9465844%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Santambrogio G

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9465844%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Alimento M

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9465844%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 January 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9465844%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9465844%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9465844%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9465844%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

79-86

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9465844%20AND%20SRC:MED&resulttype=core&format=json

Release of a Prostaglandin E-Like Substance from Canine Kidney by Bradykinin

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990123-0

Contribution of prostaglandins to the antihypertensive action of captopril in essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990123-0

The antihypertensive effect of captopril in essential hypertension: relationship to prostaglandins and the kallikrein-kinin system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990123-0

Kinins, nitric oxide, and the hypotensive effect of captopril and ramiprilat in hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990123-0

Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990123-0

Endothelium dependent vasomotor responses to endogenous agonists are potentiated following ACE inhibition by a bradykinin dependent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990123-0

Improvement of alveolar-capillary membrane diffusing capacity with enalapril in chronic heart failure and counteracting effect of aspirin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990123-0

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990123-0

The clinical significance of inhibition of renal prostaglandin synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990123-0

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990123-0

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990123-0

Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990123-0

Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990123-0

Abnormal renal sodium handling in essential hypertension. Relation to failure of renal and adrenal modulation of responses to angiotensin II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990123-0

Essential hypertension: renin and aldosterone, heart attack and stroke.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990123-0

Acute effects of captopril on blood pressure and circulating hormone levels in salt-replete and depleted normal subjects and essential hypertensive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990123-0

Evidence from a dual action of converting enzyme inhibitor on blood pressure in normal man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990123-0

Mechanism of action of antiotensin II and antidiuretic hormone on renin secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990123-0

Role of prostaglandins in the control of renin secretion in the dog

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990123-0

Renal actions of prostacyclin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990123-0

Effects of low-dose aspirin on responses to furosemide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990123-0

Aspirin lowers blood pressure in patients with renovascular hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990123-0

Aspirin as an antiplatelet drug

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990123-0

Inhibition of renin secretion by angiotensin. II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990123-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0009-9236(98)90123-0

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9465844%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference